34 results about "Plantago asiatica" patented technology

The invention discloses a preparation method and application of a medicinal and edible traditional Chinese medicine compound with an effect of treating uric acid diseases. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 15 to 25 parts of semen plantaginis, 15 to 25 parts of pawpaw, 5 to 15 parts of rhizoma smilacis glabrae, 5 to 15 parts of herba portulacae, 1 to 11 parts of radix glycyrrhizae preparata, 5 to 15 parts of folium mori, 5 to 15 parts of folium perillae, 1 to 11 parts of semen pruni, 5 to 15 parts of rhizoma polygonati, 1 to 11 parts of black dates and 1 to 9 parts of mulberries. The traditional Chinese medicine compound is composed of medicinal and edible raw materials, has stable efficacy of reducing uric acid and relieving uric acid liver and kidney injury, renal fibrosis and gouty arthritis, can relieve arthrocele caused by gout, reduces the level of joint inflammatory factors and the like, and takes effect quickly. The traditional Chinese medicine composition can be used for treating hyperuricemia, uric acid nephropathy, gouty arthritis and hyperuricemia accompanying symptoms.

The invention relates to the technical field of functional beverages, in particular to a composite polypeptide solid beverage with a uric acid reducing function and a preparation method of the composite polypeptide solid beverage. The composite polypeptide solid beverage with the uric acid reducing function is prepared from the following raw materials in percentage by weight: 15-25% of plukenetia volubilis extract, 30-40% of lysimachia christinae hance-plantain herb composite extract, 8-12% of oyster peptide powder, 5-8% of earthworm protein peptide freeze-dried powder and 3-5% of a flavoring agent. Wherein the ratio of a lysimachia christinae hance extract to a plantain herb extract in the lysimachia christinae hance-plantain herb composite extract is 3: The flavoring agent is erythritol and / or stevioside, xanthine oxidase is inhibited by using flavonoid substances, GLUT9 expression is synergistically down-regulated by using bispyribaloside, PRPP synthetase activity is regulated by using zinc-rich peptide, uric acid micro-crystals are dissolved by using earthworm protein peptide, a multi-target action network of flavonoid-glycoside-bioactive peptide is achieved, and the effect of improving the bioavailability of the flavonoid-glycoside-bioactive peptide is achieved. And triple mechanisms of excretion promotion, generation inhibition and kidney protection are realized.

To provide an endoplasmic reticulum stress suppressing composition and a liver function improving composition.SOLUTION: A composition for suppressing endoplasmic reticulum stress and / or a composition for improving hepatic functions, comprising one or more plants selected from the group consisting of Plantago asiatica, Hamilton's spindle tree, panicled hydrangea, Japanese plum yew, Japanese mallotus, and Papaver rhoeas, and / or an extract thereof.SELECTED DRAWING: None

The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a traditional Chinese medicine composition for treating damp turbidity and blood stasis type hyperuricemia or gout and a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 12-18 parts of radix paeoniae alba, 12-18 parts of yam rhizome, 45-55 parts of rhizoma smilacis glabrae, 25-35 parts of plantain herb, 8-12 parts of radix polygonati officinalis, 8-12 parts of radix cyathulae, 8-12 parts of fructus psoraleae, 7-11 parts of ground beeltle and 3-7 parts of liquorice. The traditional Chinese medicine composition is formulated according to the traditional Chinese medicine pathogenesis characteristics of hyperuricemia and gout, the whole formula takes improvement of intestinal mucosa barrier as the core, the effects of reducing the blood uric acid level, relieving symptoms and conditioning the body are achieved through diuresis promoting, turbidity removing, collateral dredging and blood stasis removing, and the traditional Chinese medicine composition is suitable for gout and hyperuricemia caused by intestinal damp turbidity and blood stasis blocking.

This invention discloses a method for determining the content of target components in Qingning Powder. Stir-fried Lepidium apetalum seeds, stir-fried Plantago asiatica seeds, and stir-fried Glycyrrhiza uralensis are dissolved in methanol solution, shaken well, filtered, and the filtrate is used to obtain a test solution for detection by high-performance liquid chromatography (HPLC). The three target components in the test solution are identified as: quercetin-3-O-β-D-glucose-7-O-β-D-gentiopicroside (C...). 33 H 40 O 22 ), genipinic acid (C 16 H 22 O 10 ), glycyrrhizin (C 21 H 22 The content of O9); the detection method using high performance liquid chromatography includes the following steps; Step 1: Take appropriate amounts of reference standards for quercetin-3-O-β-D-glucose-7-O-β-D-gentiopicroside, genipin glycoside, verbascoside, and glycyrrhizin, respectively, and weigh them accurately. This method for determining the content of target components in Qingning Powder, through monomer analysis combined with specific reference standards, breaks through the mixed bottleneck of the whole formula fingerprint spectrum and quickly locates the responsible medicinal materials of abnormal batches.

The invention provides a traditional Chinese medicine compound which is prepared from the following raw material medicines: rhizoma smilacis glabrae, rhizoma dioscoreae septemlobae, semen coicis, rhizoma curcumae longae, herba taxilli, radix salviae miltiorrhizae, cortex phellodendri, rhizoma acori graminei, plantain herb, rhizoma atractylodis macrocephalae, wine-treated rhubarb, radix angelicae pubescentis, bran-fried rhizoma atractylodis and vinegar-treated rhizoma corydalis, and also provides application of the traditional Chinese medicine compound composition in medicines for treating gout and gouty nephropathy. In addition, the invention also provides a preparation method of the sustained-release granule of the compound composition, which comprises the following steps: firstly, preparing the raw medicinal materials into a traditional Chinese medicine fluid extract, then adding the filler into the traditional Chinese medicine fluid extract, stirring to form a soft material, passing the soft material through a swinging granulator, and drying to obtain a medicine-containing pill core; and putting the pill cores into a fluidized bed, laterally spraying the slow-release coating solution, drying, and sieving to prepare the slow-release granules. The prepared traditional Chinese medicine formula sustained-release granules can release 90% or above within 8-10 hours, have a good constant-speed sustained-release characteristic, can meet the clinical requirement of 1-2 times of administration every day, and have good clinical application prospects and market value.

This invention relates to the field of traditional Chinese medicine technology, specifically to a granule for promoting urination and eliminating stones, its preparation method, and its application. The granule comprises the following ingredients: *Lysimachia christinae*, *Pyrrosia lingua*, *Cynanchum paniculatum*, talc, stir-fried chicken gizzard lining, *Polygonum aviculare*, *Dianthus superbus*, *Plantago asiatica*, *Tetrapanax papyriferus*, *Poria cocos*, *Coix lacryma-jobi*, *Paeonia lactiflora*, vinegar-processed *Corydalis yanhusuo*, *Astragalus membranaceus*, and *Achyranthes bidentata*. The entire formula integrates clearing heat and promoting urination, dissolving stones, tonifying qi and relieving pain, and guiding the medicine downwards. It primarily focuses on purging while supplementing with tonifying, achieving the combined effects of clearing heat and promoting diuresis, and dissolving stones. It is used for damp-heat accumulation, stone accumulation, or combined with deficiency of vital energy leading to urinary tract infections, stones, or hematuria. Symptoms include frequent urination, burning and stinging pain, yellow or reddish urine, abdominal cramps, difficulty urinating or stones in the urine, red tongue with yellow or greasy coating, and a slippery and rapid pulse. This composition has the effects of clearing heat and promoting diuresis, relieving strangury and expelling stones. It is used for heat strangury, stone strangury and hematuria caused by damp-heat accumulation, with symptoms such as frequent urination, burning and stinging pain, yellow or reddish urine or blood in urine, lower back and abdominal colic, difficulty in urination or gravel in urine, red tongue with yellow or yellow and greasy coating, and slippery and rapid pulse.

This invention provides a traditional Chinese medicine composition for treating viral pneumonia in calves, its preparation method, and its application, belonging to the field of veterinary drug technology. The traditional Chinese medicine composition provided by this invention comprises the following raw materials in parts by weight: 15-20 parts of Gentiana scabra, 15-20 parts of Gardenia jasminoides, 15-20 parts of Scutellaria baicalensis, 10-15 parts of Bupleurum chinense, 25-35 parts of Rehmannia glutinosa, 25-35 parts of Plantago asiatica, 15-20 parts of Alisma plantago-aquatica, 25-35 parts of Akebia trifoliata, 10-15 parts of Angelica sinensis, 25-35 parts of Smilax glabra, 15-20 parts of Dioscorea hypoglauca, 25-35 parts of Dictamnus dasycarpus, and 10-15 parts of Glycyrrhiza uralensis (processed). The traditional Chinese medicine composition of this invention can effectively treat viral pneumonia in calves, and also has advantages that antibiotics cannot possess, such as being green and safe, residue-free, having few toxic side effects, low cost, convenient production, and being less likely to produce drug-resistant bacteria.

This invention belongs to the field of traditional Chinese medicine oral decoction preparation technology. Specifically, it relates to a method for preparing a stable and safe decoction of traditional Chinese medicine composition for hepatitis, jaundice virus, cirrhosis, and ascites. The decoction is prepared by decocting the following eleven traditional Chinese medicine components: 30g of raw Lysimachia christinae, 30g of Plantago asiatica, 30g of Poria cocos peel, 30g of Dioscorea opposita, 26g of Areca catechu peel, 16g of Salvia miltiorrhiza, 16g of Bupleurum chinense, 16g of Alisma plantago-aquatica, 16g of Astragalus membranaceus, 13g of Lycopus lucidus, and 10g of processed pangolin scales. When decocting, pour the mixture into a sterilized and cleaned porcelain medicine pot, add cold water and soak for 30 minutes. Bring to a boil over high heat, then simmer over low heat for 20 minutes. Turn off the heat and let it cool slightly before drinking. This is the medicine product. By combining classical traditional methods with modern decoction technology, the decoction of these eleven traditional Chinese medicines yields a traditional Chinese medicine preparation with significant effects and convenient administration. This formula features comprehensive regulation and enhancement. It selects herbs such as Lysimachia christinae, Plantago asiatica, Poria cocos, and Salvia miltiorrhiza, which have antibacterial, drainage, dampness-removing, anti-inflammatory, and blood-stasis-removing components for liver ascites. The combination of eleven Chinese herbs has anti-inflammatory, detoxifying, and dampness-removing effects, which are beneficial for treating liver ascites lesions, removing hepatitis, jaundice, tuberculosis, damp-heat accumulation, inflammation-induced ascites, enhancing immunity, and healing effects.

This invention provides an extract of *Cimicifuga foetida*, made from *Cimicifuga foetida* produced in Guizhou Province, using an intermittent warm percolation method for water extraction. The extract contains 10%-25% cimicifugoside, 3%-15% iso-cimicifugoside, and 20%-50% plantago asiatica glycoside. The preparation method and applications are also disclosed. The *Cimicifuga foetida* extract provided by this invention has a high content of active ingredients and significant anti-inflammatory and litholytic pharmacological activities. It can be used as a raw material for the treatment and adjuvant treatment of cholecystitis, gallstones, hydronephrosis, kidney stones, nephritis, bladder stones, and uric acid stones. It can also be used as an intermediate raw material for the separation and purification of plantago asiatica glycoside, cimicifugoside, and iso-cimicifugoside chemical standards or reference standards. The preparation method provided by this invention effectively solves the problem of extraction and enrichment of active ingredients in *Cimicifuga foetida*, and has advantages such as low production cost, ease of large-scale production, and stable and controllable quality.

The invention discloses a traditional Chinese medicine compound composition and application thereof in treating chronic kidney disease related pruritus, and belongs to the field of pruritus disease treatment. The traditional Chinese medicine compound composition is prepared from the following raw materials in parts by mass: 45 parts of radix sophorae flavescentis, 45 parts of cortex dictamni, 30 parts of herba schizonepetae, 30 parts of rhizoma alismatis, 30 parts of salted semen plantaginis, 20 parts of oldenlandia diffusa, 20 parts of folium mori, 20 parts of angelica sinensis, 20 parts of ligusticum wallichii, 20 parts of radix polygoni multiflori preparata, 20 parts of astragalus membranaceus, 20 parts of semen coicis and 15 parts of pogostemon cablin. After decoction and rotary evaporation, the traditional Chinese medicine compound composition can be used for lotion / ointment for treating chronic kidney disease related pruritus, and the lotion / ointment is smeared on pruritus parts for treatment; the lotion / ointment is obvious in effect, low in cost, free of toxic and side effects, wide in medicine source and simple and feasible in treatment method.

The invention discloses a traditional Chinese medicine composition for treating hypothyroidism and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 220 to 280 parts of radix astragali seu hedysari, 140 to 190 parts of poria cocos, 100 to 150 parts of rhizoma polygonati, 100 to 150 parts of fructus ligustri lucidi, 100 to 150 parts of rhizoma smilacis glabrae, 60 to 100 parts of herba taraxaci, 60 to 100 parts of flos lonicerae, 60 to 100 parts of pericarpium citri reticulatae, 60 to 100 parts of rhizoma chuanxiong, 60 to 100 parts of herba lycopi, 60 to 100 parts of herba plantaginis and 60 to 100 parts of liquorice root. All the medicinal materials in the traditional Chinese medicine composition cooperate with one another, and the traditional Chinese medicine composition has a good treatment effect on hypothyroidism.

This invention discloses a compound stone granule for treating the urinary system, its preparation method, and its application, belonging to the field of traditional Chinese medicine preparation technology. The granules are made from Lysimachia christinae, Lygodium japonicum, Gallus gallus domesticus gizzard lining, Pyrrosia lingua, Kochia scoparia, Polygonum capitatum, Plantago asiatica, Gentiana scabra, Polygonum cuspidatum, Lysimachia christinae, Sedum sarmentosum, Zea mays silk, Epimedium brevicornu, Juncus effusus, Achyranthes bidentata, and Glycyrrhiza uralensis. Preparation involves reflux extraction with 60% ethanol three times, 2 hours each time, followed by vacuum concentration to obtain a compound stone extract. The extract is then wet-granulated with lactose at a 1:3 ratio, and dried to obtain the final product. The process of this invention has been optimized through orthogonal experiments, resulting in a stable extract yield. The particle size, moisture content, and solubility of the granules all meet the pharmacopoeia standards. A TLC-HPLC quality control method has been established. In vitro experiments have confirmed that the aqueous solution of this compound stone granules has a concentration-dependent inhibitory effect on calcium oxalate crystallization, with a high concentration inhibition rate of 39.773%. It can protect renal tubules and optimize the urinary tract microenvironment, making it suitable for the prevention and treatment of urinary system stones. The process is simple and low-cost, making it suitable for industrial production.

The invention belongs to the technical field of medicines, and particularly relates to a Beijing pharmaceutical composition for preparing a medicine for repairing liver injury, which is extracted from the following raw materials in parts by weight: 17-20 parts of oriental wormwood, 8-12 parts of polyporus umbellatus, 3-4 parts of rhizoma atractylodis, 8-12 parts of akebiaquinata, 10-14 parts of radix bupleuri, 10-14 parts of poria cocos, 10-14 parts of semen plantaginis, 10-14 parts of cape jasmine and 4-6 parts of rhizoma alismatis. The composition disclosed by the invention can effectively relieve jaundice caused by damp-heat, relieve skin and hair yellow staining and digestive tract symptoms, promote abnormal excrement recovery, improve the inflammatory state of a body, protect liver tissues, reduce necrosis, degeneration and inflammatory infiltration of liver cells, relieve hepatic congestion, regulate liver function indexes and remarkably reduce ALT and AST levels of serum. The traditional Chinese medicine composition has the effects of eliminating dampness and heat and soothing the liver to relieve pain, and can be used for people with hepatic insufficiency, abdominal pain, jaundice, bitter and sticky mouth, whole body sleepiness, chest and hypochondrium swelling and stuffiness, red tongue, yellow / yellow and greasy tongue coating and the like.

The invention discloses a Qingli decoction traditional Chinese medicine composition as well as a preparation method and application thereof, and relates to the field of Qingli decoction, the Qingli decoction traditional Chinese medicine composition comprises the following raw materials in parts by weight: 15 parts of radix scrophulariae, 12 parts of radix ophiopogonis, 12 parts of lily, 8 parts of radix bupleuri, 12 parts of radix paeoniae alba, 7 parts of pericarpium citri reticulatae, 7 parts of semen brassicae, 12 parts of selfheal, 7 parts of caulis bambusae in taeniam, 12 parts of semen plantaginis, 7 parts of akebiaquinata, 7 parts of radix gentianae and 5 parts of rhizoma coptidis. According to the Qingli decoction traditional Chinese medicine composition as well as the preparation method and the application thereof, thirteen medicinal materials including radix scrophulariae, radix ophiopogonis and the like which have definite effects of clearing heat and causing diuresis are selected and combined through scientific compatibility and optimization principles. The medicinal materials cooperate with one another to jointly exert the effects of clearing away heat and toxic materials and inducing diuresis to reduce edema, and the traditional Chinese medicine is accurately used for treating the symptoms such as cough, excessive phlegm, swollen sore throat and difficult urination caused by lung heat and damp-heat downward flow. Through scientific compatibility, the problem that the curative effect difference between different batches or patients is large due to lack of scientific verification and optimization of a traditional compound is avoided, and the high efficiency and stability of the formula are ensured.

The invention belongs to the technical field of traditional Chinese medicines for livestock and poultry, and particularly relates to a traditional Chinese medicine composition and a preparation method and application thereof. The traditional Chinese medicine composition comprises the following components in parts by weight: 1-20 parts of coptis chinensis, 5-25 parts of scutellaria baicalensis, 1-20 parts of golden cypress, 5-25 parts of honeysuckle, 1-20 parts of fructus forsythiae, 1-20 parts of semen plantaginis and 1-10 parts of liquorice. The traditional Chinese medicine composition provided by the invention has broad-spectrum antibacterial and antiviral effects, and especially can inhibit infectious bronchitis virus and escherichia coli; in addition, the salpingitis of the laying hens caused by individual infection or mixed infection of the infectious bronchitis virus and the escherichia coli can be effectively treated and / or prevented.

The invention discloses a method for realizing transient expression of exogenous target genes in rhododendron molle plants by using a vacuum agrobacterium infection method, and belongs to the technical field of forest tree genetic engineering. The method comprises the following steps: performing ultrasonic pretreatment on rhododendron molle seedlings, immersing the plants into an agrobacterium infection solution containing a target gene, performing circulating vacuum treatment with specific parameters to enable the infection solution to efficiently permeate into tissues, and finally performing shading and normal culture to complete transient expression. By optimizing the ultrasonic treatment conditions and combining the circulating negative pressure vacuum infiltration technology, the problems that a traditional injection method is low in efficiency, tedious in operation and incapable of achieving batch treatment are solved. According to the method, the conversion efficiency and expression uniformity of the exogenous gene at the whole rhododendron molle plant level are remarkably improved, the operation is simple and convenient, the period is short, the repeatability is good, and an efficient and reliable technical platform is provided for gene function research and molecular breeding of rhododendron molle and rhododendron plants.

The invention provides a method for analyzing the action mechanism of wind-dispelling five-herb decoction for treating gout based on network pharmacology and molecular docking and application, and relates to the technical field of traditional Chinese medicine information analysis, the method comprises the following steps: acquiring a common target spot of a drug target spot of the wind-dispelling five-herb decoction and a gout disease target spot; the wind-dispelling five-herb decoction comprises lysimachia christinae hance, oldenlandia diffusa, lalang grass rhizome, plantain herb Constructing a protein interaction network based on the common target; screening core targets in the protein interaction network, and identifying core active components of the Chinese herbal medicine prescription; performing pathway enrichment analysis and function enrichment analysis on the common target spot to determine a drug action mechanism; and verifying the interaction strength of the core active component and the core target spot through molecular docking. By directly calling a plurality of biological databases and integrating molecular docking verification, the analysis process is simplified, and the mechanism that the wind-dispelling five-herb decoction acts on key targets and signal pathways through core active components to treat gout is accurately disclosed.

This invention relates to the field of identification technology for traditional Chinese medicine, specifically disclosing the application of products detecting molecular markers in Plantago asiatica for the identification of Plantago asiatica, as shown in SEQ ID NO.1. The molecular marker shown in SEQ ID NO.1 provided by this invention serves as a specific sequence molecule for Plantago asiatica, and the presence or absence of this specific sequence molecule in the plant can be used to identify whether a plant is Plantago asiatica.

This invention relates to a traditional Chinese medicine composition for delaying the progression of kidney deficiency and blood stasis syndrome in diabetic nephropathy, its application, and preparation method. The composition is made from Astragalus membranaceus, Salvia miltiorrhiza, Paeonia lactiflora, Anemarrhena asphodeloides, Phellodendron chinense, Cistanche deserticola, Scutellaria baicalensis, Euonymus alatus, Schisandra chinensis, raw oyster shell, Plantago asiatica, and Artemisia annua. It has the effects of nourishing the kidneys, clearing heat, eliminating toxins, and unblocking the meridians. This traditional Chinese medicine composition can effectively delay the decline in renal function in patients with massive proteinuria during the diabetic nephropathy stage, improve the clinical symptoms of patients with kidney deficiency and blood stasis syndrome, and improve their quality of life. Simultaneously, it has a low risk of hyperkalemia and gastrointestinal bleeding, and no significant damage to liver function has been observed, indicating high safety.

The present disclosure provides a traditional Chinese medicine composition for treating gout and uric acid nephropathy, and a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition comprises the following raw medicinal materials in parts by weight: 20-30 parts of smilax glabra, 20-30 parts of phragmites communis, 10-15 parts of atractylodes lancea, 10-15 parts of phellodendron amurense, 10-15 parts of cyathula officinalis, 20-30 parts of coicis semen, 10-20 parts of lonicera japonica, 10-15 parts of acanthopanax, 5-10 parts of eupolyphaga, 5-10 parts of rhizoma corydalis, 10-15 parts of salvia miltiorrhiza, and 15-30 parts of plantago asiatica. The traditional Chinese medicine composition can effectively treat gout and uric acid nephropathy.

Abstract: This invention discloses a traditional Chinese medicine composition (Da Zhuque Decoction) with multi-target antiviral and anti-inflammatory activities, its preparation method, and its application. The composition consists of the following raw materials in parts by weight: Alisma plantago-aquatica 2-4 parts, Prunus armeniaca 4-6 parts, Chrysanthemum indicum 4-6 parts, Artemisia annua 5-7 parts, Morus alba leaf 5-7 parts, Gypsum 5-7 parts, Poria cocos 7-9 parts, Scutellaria baicalensis 8-10 parts, Rehmannia glutinosa 8-10 parts, Plantago asiatica 11-13 parts, Taraxacum mongolicum 14-16 parts, and Glycyrrhiza uralensis 3-5 parts. This invention overcomes the limitations of traditional qualitative formulation of traditional Chinese medicines. By limiting the specific synergistic ratio of artemisinin and baicalin (1:2.5~3.0), it achieves highly efficient inhibition of respiratory viruses (IC50=12.5μg / mL) and significant downregulation of inflammatory factors (IL-6, TNF-α). Meanwhile, the preparation process of "plaster decoction first - licorice extraction alone" solves the problem of easy decomposition of heat-sensitive components, increasing the artemisinin retention rate to over 95%. This invention has a clear material basis, controllable quality, and is suitable for preparing drugs or health products for the prevention and treatment of viral pneumonia.

The invention provides a traditional Chinese medicine composition as well as a preparation method and application thereof. Specifically, the traditional Chinese medicine composition comprises active ingredients and auxiliary materials, and the active ingredients are prepared from the following raw materials: pollen typhae, radix salviae miltiorrhizae, radix rehmanniae, herba ecliptae, flos chrysanthemi, radix scutellariae, semen cassiae, plantago asiatica, fructus leonuri, fructus ligustri lucidi, spica prunellae, radix gentianae, radix curcumae, herba equiseti hiemalis, radix paeoniae rubra, cortex moutan, fructus crataegi, radix angelicae sinensis and rhizoma chuanxiong; wherein the auxiliary material does not contain dextrin; wherein the content of tanshinol in the traditional Chinese medicine composition is 0.10%-0.20%. The content of tanshinol in the traditional Chinese medicine composition is higher, and the traditional Chinese medicine composition has better efficacy, meets the requirements of the pharmaceutical process, has better fluidity and is more beneficial to preparation of subsequent preparations.

This invention discloses a formula for nourishing the kidneys, clearing heat, promoting diuresis, and resolving blood stasis, and its application. The formula comprises the following ingredients in parts by weight: Anemarrhena asphodeloides 7-13 parts, Rehmannia glutinosa 7-13 parts, Trionyx sinensis 12-18 parts, Dianthus superbus 7-13 parts, Dendrobium nobile 7-13 parts, Prunus persica 7-13 parts, Trichosanthes kirilowii 9-15 parts, Coptis chinensis 2-7 parts, Phellodendron chinense 7-13 parts, Cinnamomum cassia 2-7 parts, and Plantago asiatica 7-13 parts. This formula, provided by this invention, not only treats polycystic ovary syndrome but also significantly improves quality of life and has a role in preventing and treating depression. The present invention discloses a kidney-nourishing, heat-clearing, dampness-dispelling, and blood stasis-resolving formula and its application. The formula comprises the following raw materials by weight: 7-13 parts of Anemarrhena asphodeloides, 7-13 parts of Rehmannia glutinosa, 12-18 parts of turtle shell, 7-13 parts of Desmodium styracifolium, 7-13 parts of Dendrobium, 7-13 parts of peach kernel, 9-15 parts of Trichosanthes seed, 2-7 parts of Coptis chinensis, 7-13 parts of Phellodendron amurense, 2-7 parts of cinnamon twig, and 7-13 parts of Plantago major. The kidney-nourishing, heat-clearing, dampness-dispelling, and blood stasis-resolving formula provided by this invention is capable of significantly improving the quality of life and preventing depression while treating polycystic ovary syndrome.

This invention belongs to the field of pet food processing and relates to a premix for improving the urinary tract health of pets. The premix contains the following components in parts by weight: 25-35 parts of Dioscorea opposita, 25-35 parts of Poria cocos, 15-25 parts of Taraxacum mongolicum, 15-25 parts of Centella asiatica, 15-25 parts of Plantago asiatica, 5-15 parts of Polygonatum sibiricum, 5-15 parts of Cornus officinalis, and 5-15 parts of Lycium barbarum. Adding this premix to the cat's diet reduces serum creatinine, blood urea nitrogen, and serum oxalate concentrations, affecting oxalate absorption and excretion, and preventing the formation of calcium oxalate stones. This premix can alleviate the nephrotoxicity of sodium oxalate in cats, improve renal physiological indicators, reduce the formation of calcium oxalate stones, and provide a basic guarantee for the treatment of chronic urinary system diseases. This premix can improve the urinary tract health of cats.

This invention discloses a traditional Chinese medicine composition for treating hyperuricemia of the spleen and kidney deficiency with turbidity syndrome, its preparation method, and its application, belonging to the field of pharmaceutical technology. The composition consists of Euryale ferox, Rosa laevigata, Plantago asiatica, Alisma plantago-aquatica, Cimicifuga foetida, Smilax glabra, and Portulaca oleracea in specific weight proportions. The active ingredients are prepared using a combination of ethanol reflux extraction and water extraction, and can be further formulated into capsules, pills, granules, tablets, and other traditional Chinese medicine preparations. This invention has high safety, few side effects, and good patient compliance, making it suitable for long-term intervention and providing a new approach for the treatment of hyperuricemia with traditional Chinese medicine.

A traditional Chinese medicine composition for nourishing kidney, clearing heat, removing dampness and removing blood stasis, an extract, a pharmaceutical preparation, a preparation method and an application thereof. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: Anemarrhena asphodeloides 7-13 parts, Rehmannia glutinosa 7-13 parts, Trionyx sinensis 12-18 parts, Viola mandshurica 7-13 parts, Dendrobium 7-13 parts, Semen Pruni 7-13 parts, Semen Cucurbitae 9-15 parts, Coptis deltoidea 2-7 parts, Phellodendron amurense 7-13 parts, Cinnamomum cassia 2-7 parts, Plantago asiatica 7-13 parts, and Glycyrrhiza uralensis 2-12 parts. The traditional Chinese medicine composition can treat polycystic ovary syndrome, and can also significantly improve the quality of life and has the effect of preventing and treating depression.

The invention relates to the technical field of Chinese herbal medicine identification, and particularly discloses application of a product for detecting a molecular marker in plantago asiatica in identification of plantago asiatica, and the molecular marker is as shown in SEQ ID NO.1. The molecular marker as shown in SEQ ID NO.1 is used as a specific sequence molecule of plantago asiatica, and whether a plant is plantago asiatica or not can be identified by detecting whether the specific sequence molecule exists in the plant or not.

The invention discloses a traditional Chinese medicine composition for treating urinary calculi and a preparation method, a traditional Chinese medicine preparation and application thereof, and belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-30 parts of astragalus membranaceus, 10-30 parts of poria cocos, 10-30 parts of polyporus umbellatus, 8-20 parts of rhizoma alismatis, 8-20 parts of rhizoma corydalis, 8-20 parts of rhizoma cyperi, 8-20 parts of lindera aggregata, 10-20 parts of pyrrosia lingua, 10-20 parts of talc, 10-20 parts of semen plantaginis, 10-30 parts of dianthus superbus, 10-25 parts of radix paeoniae alba, 10-30 parts of endothelium corneum gigeriae galli, 10-30 parts of lygodium japonicum, 10-30 parts of lysimachia christinae hance and 3-10 parts of liquorice. The traditional Chinese medicine composition can improve the calculus removal efficiency of calculus insensitive to ESWL or postoperative residual calculus. The invention provides a compound scheme with comprehensive effects of dissolving stones, removing stones, relieving spasm, relieving pain, resisting inflammation and repairing tissues.

This invention discloses a plantago rhizosphere strain and its application in the control of rice diseases. The strain is *Pleurotus erythroptera* RSP5, and its classification name is *Pleurotus erythroptera* (…). Talaromyces purpureogenus The strain described in this application, with accession number CGMCC No. 41720, is a purple basket-forming bacterium RSP5 isolated from the rhizosphere soil of Plantago asiatica. This strain not only promotes the growth of rice plants but also exhibits good growth inhibition against rice sheath blight, rice blast, bacterial leaf streak, and bacterial blight. It can be used alone or in combination with pesticides for the control of rice-related diseases.